L
Luis M. Ruilope
Researcher at European University of Madrid
Publications - 891
Citations - 109166
Luis M. Ruilope is an academic researcher from European University of Madrid. The author has contributed to research in topics: Blood pressure & Renal function. The author has an hindex of 94, co-authored 841 publications receiving 97778 citations. Previous affiliations of Luis M. Ruilope include Lund University & Mayo Clinic.
Papers
More filters
Journal ArticleDOI
The protective role of atorvastatin on function, structure and ultrastructure in the aorta of dyslipidemic rabbits.
Paloma Aragoncillo,Rosaura Maeso,S. Vázquez-Pérez,Josefa Navarro-Cid,Luis M. Ruilope,C. Diaz,Gonzalo Hernández,Vicente Lahera,Victoria Cachofeiro +8 more
TL;DR: Chronic atorvastatin treatment exerts a protective role in vascular function, structure and ultrastructure even in the presence of high cholesterol and triglyceride plasma levels.
Journal ArticleDOI
Renal denervation in patients with versus without chronic kidney disease: results from the global SYMPLICITY Registry with follow-up data of 3 years.
Christian Ott,Felix Mahfoud,Giuseppe Mancia,Krzysztof Narkiewicz,Luis M. Ruilope,Martin Fahy,Markus P. Schlaich,Michael Böhm,Roland E. Schmieder +8 more
TL;DR: In this paper, the authors compared short and long-term blood pressure (BP) lowering effects of renal denervation (RDN) between hypertensive patients with or without CKD in the Global SYMPLICITY Registry.
Journal ArticleDOI
Intervention at lower blood pressure levels to achieve target goals in type 2 diabetes: PRADID (PResión Arterial en DIabéticos tipo Dos) study.
TL;DR: Antihypertensive treatment is more effective than placebo for controlling SBP and DBP in previously untreated participants with type 2 diabetes exhibiting low threshold BP values.
Journal ArticleDOI
Control of hypertension in coronary heart disease.
José R. Banegas,A. de la Sierra,Julian Segura,Manuel Gorostidi,J. J. De La Cruz,Fernando Rodríguez-Artalejo,Luis M. Ruilope +6 more
TL;DR: Out-of-office control of hypertension among 2434 treated essential hypertensive patients with clinically documented CHD was much higher than in-office BP control; physicians should be comforted by BP results better than previously believed based on office data.
Journal ArticleDOI
Hypertension and obesity: correlates with renin-angiotensin-aldosterone system and uric acid.
TL;DR: It is described that serum uric acid seems to contribute to the enhancement of plasma angiotensinogen and could be involved in the pathophysiology of obesity-related hypertension where an increase in activity of RAAS is one of the mechanisms underlying the development and maintenance of arterial hypertension.